Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O3158 ION RELEASE AND CHROMOSOMAL DAMAGE FROM TOTAL HIP PROSTHESES WITH METAL-ON- METAL ARTICULATION



Abstract

Aims: A prospective multicentric study was carried out in patients having metal-on-metal METASUL components to check if the concentration markers of chromosomal damage (Sister Chromatid Exchanges (SCEñs) and Micronuclei (Mni) and that of Co, Cr, Ni and Mb in the body ßuids are affected by the implant of METASUL components within 6 months. Methods: 30 patients were enrolled homogeneous as to the exposition to mutagenic agents. Observation times were pre-op., 7 days, 2 months, 6 months; blood and urine samples were taken at each observation time, and the markers of chromosomal damage (blood) and the ion concentration (blood and urine) were measured. Results: measurements showed a 2-fold increase of Co in blood, a 10-fold increase of Co in urine, a 1.5-fold increase of Cr in the blood and a 3-fold increase of Cr in the urine at a follow-up of 6 months from the operation; the Ni blood concentration was also increased at the 7 day check-up. The study cohort did not show any modiþcation in the frequency of markers of chromosomal damage at any of the observation times. The amount of the SCEñs and Mni recorded at all the observation times did non correlate with each other nor with any of the ion levels measured in the blood and in the urine. Conclusions: the implant of prostheses with METASUL components determines an increase in the concentrations of mainly Co and Cr in blood and urine, but that this increase has no genotoxic effects on the peripheral lymphocytes in the selected group at a follow-up of 6 months.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.